Trial Profile
Effects of a 10 or 15 mg single intravenous bolus of ivabradine versus placebo on heart rate control during a multislice computed tomography coronary angiography for the evaluation of coronary artery disease. A randomised, double-blind, international, multi-centre study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Oct 2021
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Coronary artery disease
- Focus Pharmacodynamics
- Sponsors Servier
- 25 Jul 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 24 Mar 2012 This trial is recruiting in United Kingdom, Spain and France.
- 31 May 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.